Tech Company Financing Transactions
Enumeral Biomedical Funding Round
Enumeral Biomedical, based in Cambridge, raised $635 thousand from private investors.
Transaction Overview
Company Name
Announced On
2/11/2014
Transaction Type
Debt
Amount
$635,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
200 Cambridge Park Dr.
Cambridge, MA 02140
USA
Cambridge, MA 02140
USA
Phone
Website
Email Address
Overview
Enumeral Biomedical uses a nanotechnology-enabled process for therapeutic discovery, immune profiling and personalized medicine.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kevin Sarney
VP - General Counsel
Matthew Ebert
Browse more venture capital transactions:
Prev: 2/11/2014: Kaltura venture capital transaction
Next: 2/11/2014: 365 Retail Markets venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on all VC transactions involving tech companies. VC transactions reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs